Patients Coming Off Weight-Loss Injections Gain Back Weight Four Times Faster Compared to Dieters

New research reveals that individuals who discontinue popular GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who halt conventional lifestyle plans.

Research printed in a prominent health publication shows that while obese people can lose substantial amounts of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Users buying these drugs need to be cognizant of the risk of quick rebound weight gain when the treatment ends," warns lead investigator Dr. Susan Jebb.

That rate of regain means a return to starting mass within about 18 months.

Analyzing Therapies

The analysis, which reviewed 37 of studies involving thousands of patients, compared the outcomes of these new drugs with older methods.

Researchers emphasize that people who lose weight through diet and exercise generally see a more gradual weight regain—around 100 grams monthly—after stopping.

Understanding the Quick Regain

Nutrition scientists believe the way of the jabs is key to understanding the accelerated rebound.

These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing the hormone levels far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' leads to hunger is uncontrolled, making binge eating a significant risk."

A Chronic Condition?

Health authorities recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

Professionals say that, due to the likelihood of relapse, the therapy might need to be ongoing.

This view is echoed by drug manufacturers, who state that the results "emphasize the long-term nature of obesity," akin to managing diseases like high blood pressure.

Patient Testimonies

People who have stopped the jabs report a sudden resurgence of appetite.

"I experienced a trigger that goes on and you become extremely hungry," described one woman.

The struggle is worsened if users have not adopted permanent dietary or behavioural modifications during therapy.

Growing Adoption

Figures show that millions of adults in the UK have used these injections in the past year, with desire continuing to grow.

• Use is higher among women than males.
• The middle-aged age group shows the greatest usage rates.
• Many obtain the medications through private healthcare rather than the NHS.

In conclusion, researchers stress that while GLP-1 drugs are powerful agents for weight loss, they are not a standalone solution and lasting health benefits relies on combined lifestyle management.